The effect of guanethidine and local anesthetics on the electrically stimulated mouse vas deferens

Anesthesia and Analgesia

Volumn 95, Issue 5, 2002, Pages 1339-1343

  Joyce, Philip I ^a   Rizzi, Daniela ^a   Caló, Girolamo ^a   Rowbotham, David J ^a   Lambert, David G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; GUANETHIDINE; LOCAL ANESTHETIC AGENT; NORADRENALIN; PRILOCAINE; PROCAINE;

ADRENERGIC ACTIVITY; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DRUG EFFICACY; ELECTROSTIMULATION; INHIBITION KINETICS; LOCAL ANESTHESIA; MALE; MOUSE; MUSCLE TWITCH; NERVE BLOCK; NONHUMAN; NORADRENALIN UPTAKE; ORGAN CULTURE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; VAS DEFERENS;

ADRENERGIC AGENTS; ADRENERGIC ALPHA-ANTAGONISTS; ANESTHETICS, LOCAL; ANIMALS; COCAINE; ELECTRIC STIMULATION; GUANETHIDINE; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PRAZOSIN; PRILOCAINE; PROCAINE; TETRODOTOXIN; VAS DEFERENS;

EID: 0036830317     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200211000-00045     Document Type: Article

References (16)

1. Bonica JJ. Causalgia and other reflex sympathetic dystrophies. In: Bonica JJ, ed. The Management of Pain. 2nd Ed. Philadelphia: Lea & Febiger, 1990:220-43.
2. Hanningon-Kiff JG. Intravenous regional sympathetic block with guanethidine. Lancet 1974;1:1019-20.
3. Hanningon-Kiff JG. Relief of Sudeck's atrophy by regional intravenous guanethidine. Lancet 1977;1:1132-3.
4. Hanningon-Kiff JG. Relief of causalgia in limbs by regional intravenous guanethidine. BMJ 1979;2:367-8.
5. Hanningon-Kiff JG. Hyperadrenergic-effected limb causalgia: Relief by pharmacologic norepinephrine blockade. Am Heart J 1982;103:152-3.
6. Maxwell RA. Guanethidine after twenty years: A pharmacologist's perspective. Br J Pharmacol 1982;13:35-44.
7. Gordon N. Reflex sympathetic dystrophy [review]. Brain Dev 1996;18:257-62.
8. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-39.
9. Sora I, Hall FS, Andrews AM, et al. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A 2001;98:5300-5.
10. 3H]nisoxetine binding to recombinant human norepinephrine transporters. Br J Pharmacol 1999; 128:178P.
11. Joyce PI, Atcheson R, Marcus RJ, et al. Interaction of local anaesthetic agents with the endogenous norepinephrine transporter in SH-SY5Y human neuroblastoma cells. Neurosci Lett 2001;305:161-4.
12. Calo' G, Rizzi A, Bodin M, et al. Pharmacological characterization of nociceptin receptor: An in vitro study. Can J Physiol Pharmacol 1997;75:713-8.
13. 3H]Nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J Pharmacol Exp Ther 1992;260:427-36.
14. 3H]Nisoxetine: A new radioligand for norepinephrine uptake sites in brain. Eur J Pharmacol 1990;191:239-43.
15. Albers FW. The clinical use of cocaine in rhinosurgery: A casereport and a review. Rhinology 1990;1:55-9.
16. Hageluken A, Grunbaum L, Nurnburg B, et. al., Lipophilic β-adrenoceptor antagonists and local anesthetics are effective direct activators of G-proteins. Biochem Pharmacol 1994;47: 1789-95.